Member Info for MrRipley

Then **** off at 1.40 busy builder. By the way I’m a builder too, and I bet you’re ****.

You’re very sensitive for a cabbie cabbieray. But then cabbies know everything so I bow, quivering like a ****ting dog to your breadth of knowledge…. Anyway. You been busy mate?

I wonder sometimes if people post this kind of **** to get an idea of what the company has in store because they’re too lazy and thick to do their own research. Strip the whole company back and just leave PreCision. If AVA6000 proves proof of concept and safety, improvement to patient care and reduction of side effects then what is that platform worth alone?

So you believe that in 2022 if AVA6000 comes back with great results and with the projected 5-10% share of a 3-5bn doxorubicin market is achieved that we would be worth less than a billion? Before adding in the LG deal, the Daewoong Deal, any Affidx revenue and anything at all for TMAC or the affimer IP and the potential revenue from the current licensing deals and any future deals? I’ll put this as politely as you deserve; you’re a thick twat.

What’s for Christmas dinner this year NDN? Breast? Thigh? Most peoples major issue is carving the turkey but you aren’t eating turkey are you? Your main problem is getting rid of the hair and teeth so they can’t track the dental records. Finger sniffer.

One post yesterday and he’s back with the TA ****e. Literally like a broken record.
CE for self use.
AVA in clinic.
Next candidate announced soon.
Desk top review.
TT
Orders.

Forget TA. This is a news share. That complete moron sealion vanishes on a good day then come back with this complete crap. Just block the twat

https://m.youtube.com/watch?v=IjaK6MqxKNA

Black cat. Bit of confusion on your part.
Our test is an antigen test. Nobody is using antibody tests really. But what I think you mean is Monoclonal Antibody based assays. We have an affimer based assay. That’s our advantage that we’re using Affimers which are much faster to produce than MAbs depending on how the virus mutates (s vs n). But you’re correct. We do have an advantage vs MAbs.

Ahhhh haha it’s brutal on here tonight laaaa. The fantom bus seat sniffer will be frothing.

Twat

So they’ve dropped 131k on these shares and they have to hold them til the 29th? What news are they expecting (been told we’re getting) before then? That’s not chump change is it.

Haha or as ****s say, LOL

For info sake we had app 5.5m shares bought vs 3.5 sold (give or take) and are up 17%. ODX had the opposite and are up 18%. Someone mind doing that maths for me? Is this the matrix?

Mates letting mates know?

Avacta Group plc (AIM: AVCT), a clinical stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, today announces that following the exercise of share options by a former employee it has issued and allotted in total 111,607 new ordinary shares of 10 pence each in the Company ("Ordinary Shares").

Get what sorted you thick fuc@?
So…. Desk top review, ABDX TT complete, dose escalation, and first readout all still on the horizon.
ABDX TT complete Friday morning. You heard it here first.

No need to thank me.

Total ********

Translation. I’ve just swallowed my pride and bought in. Bell end.

Hope it’s put a spring in your step(on)…. Zoom. See what I did there?

Come on zoom! Sing it with me!

https://m.youtube.com/watch?v=KnBi-LNM0Og

Woah woah woah. Are you suggesting that isn’t real? It must be, the letters are all red and the man who sent it to me had a thick Yorkshire accent with lots of t and ‘nt nt’dat liiiike. Apparently each order comes with a free ferret and some drizzle

Eastside is becoming my favourite poster quite quickly.

Then what, pray tell, is this?

https://mobile.twitter.com/MrRipley21/status/1473406020470943749